Prepared as a catalog companion to the model testing report.
Ingredient list
Declared composition for a LIRAVEXIN catalog item — not a tested result
Declared ingredients
| Ingredient | Amount as declared | Public identity |
|---|---|---|
| CJC-1295 with DAC | 10 mg | A modified GRF (1–29) analogue conjugated to a drug-affinity complex (DAC) designed to bind albumin. The peptide portion corresponds to modified GRF (1–29); the conjugation chemistry is not restated here in full. Public sequence / structure: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg, with a DAC (maleimidopropionyl) modification |
| Other constituents | — | Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here. |
Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.
Permalink
The QR code on the model report opens this page.
Published address:
https://gs-laboratory.com/ingredients/cd10.html
This is the published address of this ingredient list.
Notes
This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.
The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.